UBS Group AG - ZOMEDICA PHARMACEUTICALS COR ownership

ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 37 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ZOMEDICA PHARMACEUTICALS COR
ValueSharesWeighting
Q3 2020$12,000
-7.7%
105,639
+92.2%
0.00%
Q2 2020$13,000
+30.0%
54,974
+9.4%
0.00%
Q1 2020$10,000
+11.1%
50,247
+90.0%
0.00%
Q4 2019$9,000
-60.9%
26,439
-58.1%
0.00%
Q3 2019$23,000
+130.0%
63,114
+48.3%
0.00%
Q2 2019$10,000
+233.3%
42,559
+460.0%
0.00%
Q1 2019$3,000
-88.5%
7,600
-63.5%
0.00%
Q4 2018$26,000
+4.0%
20,845
+58.3%
0.00%
Q3 2018$25,000
+19.0%
13,172
+38.7%
0.00%
Q2 2018$21,0009,495
+19277.6%
0.00%
Q1 2018$0
-100.0%
49
-98.7%
0.00%
Q4 2017$8,0003,8640.00%
Other shareholders
ZOMEDICA PHARMACEUTICALS COR shareholders Q2 2018
NameSharesValueWeighting ↓
Cambridge Investment Research Advisors, Inc. 12,254,080$1,349,0000.01%
SABBY MANAGEMENT, LLC 470,548$52,0000.01%
jvl associates llc 58,500$6,0000.01%
WINTON GROUP Ltd 717,882$79,0000.00%
REILLY FINANCIAL ADVISORS, LLC 172,031$19,0000.00%
THOROUGHBRED FINANCIAL SERVICES, LLC 21,000$2,0000.00%
RETIREMENT INCOME SOLUTIONS, INC 32,060$3,000,0000.00%
JANE STREET GROUP, LLC 223,538$25,0000.00%
Sequoia Financial Advisors, LLC 15,000$2,0000.00%
UBS Group AG 105,639$12,0000.00%
View complete list of ZOMEDICA PHARMACEUTICALS COR shareholders